The market is expected to consolidate with a negative bias, while volatility is expected to remain high. Below are some ...

The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's profit stood at Tk 21.08 crore in Q2. Shares of the company went up 0.24 ...

The government may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025 ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...

The Ibn Sina Pharmaceutical Industry's profit grew marginally in the second quarter of fiscal year 2024-25. The company's ...

HC Wainwright reaffirmed their buy rating on shares of Arrowhead Pharmaceuticals (NASDAQ:ARWR – Free Report) in a research ...

Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) had its price target raised by UBS Group from $28.00 to $30.00 in a research note published on Thursday,Benzinga reports. UBS Group currently ...

It’s shaping up as a big year for late-stage Australian-listed drug developers, with analysts tipping potentially hefty share ...

Bangalore: Strides Pharma Science Limited has announced that the Company has received an ESG score of 76/100 and CSA score of ...